Literature DB >> 8320182

Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

M E Berens1, G Bjotvedt, D C Levesque, M D Rief, J R Shapiro, S W Coons.   

Abstract

Tumor cells from a spontaneously arising canine astrocytoma were isolated and cloned. Three clonally derived cell lines (DL3580 clone 1, DL3580 clone 2, and DL3580 clone 3) were developed and found to express glial fibrillary acidic protein (GFAP) as well as epidermal growth factor receptor (EGFR/c-erbB1). The cell lines were tumorigenic as subcutaneous xenografts or as intracranial implants in athymic mice, or both. Both the monolayer astrocytoma cells and the xenograft tumor cells from clone 2 were aneuploid, with a modal number of 84 chromosomes per metaphase; clones 1 and 3 were also aneuploid with modal numbers of 82 and 75/79, respectively. The histology of both the initial spontaneously occurring tumor in the dog and the intracranial astrocytoma in athymic mice demonstrated features of diffuse infiltration into normal brain. These newly developed canine glioma cell lines are karyotypically stable for 1 yr in culture and carry the same marker chromosomes as the parental lines. These glioma cell lines may serve as models for investigating mechanisms of glioma invasion into brain. Additionally, clonal cell lines with divergent properties isolated from the same tumor may assist in studies of the molecular basis of astrocytoma progression and heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320182     DOI: 10.1007/bf02633959

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  42 in total

Review 1.  Chemical carcinogenesis in the nervous system.

Authors:  P Kleihues; P L Lantos; P N Magee
Journal:  Int Rev Exp Pathol       Date:  1976

2.  Spontaneous central nervous system tumors in the dog.

Authors:  F A Zaki
Journal:  Vet Clin North Am       Date:  1977-02

Review 3.  Treatment of neuroectodermal brain tumors.

Authors:  W R Shapiro
Journal:  Ann Neurol       Date:  1982-09       Impact factor: 10.422

4.  Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas.

Authors:  J R Shapiro; W K Yung; W R Shapiro
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

Review 5.  Growth factors and oncogenes in human malignant glioma.

Authors:  B Westermark; M Nister; C H Heldin
Journal:  Neurol Clin       Date:  1985-11       Impact factor: 3.806

6.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Authors:  A J Wong; S H Bigner; D D Bigner; K W Kinzler; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  CT characteristics of a transplantable canine glioma model: preliminary kinetic analysis.

Authors:  M Salcman; K C Rao; E W Scott; E H Bellis; O R Blaumanis
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

8.  Disseminating tumor cells and their interactions with leukocytes visualized in the brain.

Authors:  L A Lampson; P Wen; V A Roman; J H Morris; J A Sarid
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

9.  Computed tomographic characteristics of primary brain tumors in 50 dogs.

Authors:  J M Turrel; J R Fike; R A LeCouteur; R J Higgins
Journal:  J Am Vet Med Assoc       Date:  1986-04-15       Impact factor: 1.936

10.  Immunophenotypic differences between normal glia, astrocytomas and malignant gliomas: correlations with karyotype, natural history and survival.

Authors:  M T Jennings; S A Ebrahim; H T Thaler; V D Jennings; L L Asadourian; J R Shapiro
Journal:  J Neuroimmunol       Date:  1989-11       Impact factor: 3.478

View more
  9 in total

1.  Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.

Authors:  M Sena-Esteves; Y Saeki; S M Camp; E A Chiocca; X O Breakefield
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

3.  Adenoviral-mediated gene transfer into the canine brain in vivo.

Authors:  Marianela Candolfi; Kurt M Kroeger; G Elizabeth Pluhar; Josee Bergeron; Mariana Puntel; James F Curtin; Elizabeth A McNiel; Andrew B Freese; John R Ohlfest; Peter Moore; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

4.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

Review 5.  Comparative aspects of neoplastic invasion of the brain.

Authors:  H E Kaiser
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.

Authors:  Y Otani; T Ichikawa; K Kurozumi; S Inoue; J Ishida; T Oka; T Shimizu; Y Tomita; Y Hattori; A Uneda; Y Matsumoto; H Michiue; I Date
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

7.  Proteomics-based analysis of invasion-related proteins in malignant gliomas.

Authors:  Tomoko Maruo; Tomotsugu Ichikawa; Hirotaka Kanzaki; Satoshi Inoue; Kazuhiko Kurozumi; Manabu Onishi; Koichi Yoshida; Hirokazu Kambara; Mamoru Ouchida; Kenji Shimizu; Seiji Tamaru; E Antonio Chiocca; Isao Date
Journal:  Neuropathology       Date:  2012-11-01       Impact factor: 1.906

Review 8.  Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.

Authors:  Upasana Sahu; Rolf F Barth; Yoshihiro Otani; Ryan McCormack; Balveen Kaur
Journal:  J Neuropathol Exp Neurol       Date:  2022-04-27       Impact factor: 3.148

9.  Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.

Authors:  Yuji Matsumoto; Tomotsugu Ichikawa; Kazuhiko Kurozumi; Yoshihiro Otani; Atsushi Fujimura; Kentaro Fujii; Yusuke Tomita; Yasuhiko Hattori; Atsuhito Uneda; Nobushige Tsuboi; Keisuke Kaneda; Keigo Makino; Isao Date
Journal:  Acta Neuropathol Commun       Date:  2020-04-05       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.